INTRODUCTION
============

Increasing levels of intramuscular fat (IMF) content has a positive impact on the meat quality of pork \[[@b1-ajas-30-3-338]\]. The fatty acid (FA) composition of pork is an important factor in defining lipid quality due to its implications for human health \[[@b2-ajas-30-3-338]\]. Fat deposition and fatty acid composition in pork are very complex traits that are likely to be controlled by a variety of genes \[[@b3-ajas-30-3-338]\]. There have been several attempts made to identify the quantitative trait loci (QTL) for IMF content and FA composition in pigs using microsatellite markers \[[@b2-ajas-30-3-338],[@b4-ajas-30-3-338],[@b5-ajas-30-3-338]\]. Recently, advances in the high-density single nucleotide polymorphisms (SNPs) chip approach have allowed for the genotyping of a large number of SNPs throughout the genome \[[@b6-ajas-30-3-338]\]. The genome wide association study approach has been carried out to detect QTLs affect on IMF and FA content in the muscle tissue of pigs \[[@b7-ajas-30-3-338]--[@b9-ajas-30-3-338]\]. Empirical evidence of identifying QTL for IMF and FA content traits have been successfully performed using F2 or crossbred experimental populations, e.g. Iberian and Landrace \[[@b7-ajas-30-3-338]\], White Duroc and Erhualian \[[@b9-ajas-30-3-338]\], Yorkshire and Korean native pigs \[[@b10-ajas-30-3-338]\]. However, QTL segregation must be confirmed in different breeds for successful marker-assisted and genomic selection \[[@b5-ajas-30-3-338]\]. Very few research efforts have undertaken the QTL for IMF and FA content traits in the commercial line pig breeds \[[@b4-ajas-30-3-338],[@b8-ajas-30-3-338]\]. Genome scanning of chromosome regions for IMF and FA content traits in the commercial lines is important for improving meat quality in the pig production process.

Amplified fragment length polymorphism (AFLP) genome scan is an alternative relevant approach in detecting potential genetic markers with specific traits. It is a robust and highly-throughout tool for screening the whole genome and produces a large number of markers that can be converted to simple codominant locus-specific markers without prior knowledge of the specific sequences \[[@b11-ajas-30-3-338]\]. The AFLP approach has been used to successfully identify the QTLs for meat quality and carcass traits in both pigs and cattle \[[@b11-ajas-30-3-338],[@b12-ajas-30-3-338]\]. In this present study, we identified and evaluated the effects of novel SNP markers for IMF and FA composition in the *longissimus dorsi* (LD) muscle tissue of the commercially crossbred pigs using the AFLP approach.

MATERIALS AND METHODS
=====================

Animals, DNA isolation, intramuscular fat, and fatty acid content determination
-------------------------------------------------------------------------------

The study protocol was approved by the Animal Ethics Committee of the Faculty of Agriculture, Chiang Mai University, Thailand. A total of 620 commercially crossbred pigs (Duroc and Large White×Landrace) (322 gilts and 298 barrows) were reared under commercial conditions. Animals were slaughtered according to applicable standards at the slaughter-weight of 90 kg. The LD muscles were collected from the 10th rib for DNA extraction and for IMF content measurement. The genomic DNA was extracted according to the standard phenol-chloroform protocol. The IMF content of each LD sample was determined by the ether extraction method and expressed as the percentage of IMF in fresh meat. Fatty acid composition was determined by using a gas chromatography apparatus (SCION 456-GC, Bruker Daltonic Inc, Fremont, CA, USA) with a RT-2560 capillary column (RESTEK, Bellefonte, PA, USA). Fatty acid composition was reported as the percentage of total fatty acids.

Amplified fragment length polymorphism analysis
-----------------------------------------------

The AFLP analysis was conducted by selecting the specimens with the 20 highest- and 20 lowest-IMF content from the 620 commercially crossbred pigs. The AFLP procedures were performed according to the previous study \[[@b11-ajas-30-3-338]\]. Genomic DNA samples (250 ng) were digested with FastDigest *EcoR*I and subsequently with FastDigest *Taq*I (Fermentas, Hanover, MD, USA) based on the manufacturer's instructions. Restriction fragments were ligated to 10 pmol of *EcoR*I-adapters and 50 pmol of *Taq*I-adapters in 30 μL of the ligation mixture that contained 1 U T4 DNA ligase. The reaction was incubated at 20°C for 2 h and then at 4°C overnight. The ligated DNA fragments were diluted 1:5 with double-distilled water and used as a template for amplification. Pre-selective amplification was performed in 25 μL containing 10 ng of diluted ligation fragments, 1× *Taq* Buffer (20 mM Tris--HCl, pH 8.4, 50 mM (NH~4~)~2~SO~4~; Fermentas, USA), 3.0 mM MgCl~2~, 0.25 mM each of the four dNTPs, 0.25 U *Taq* DNA polymerase (Fermentas, USA), 4 pmol of *Eco*RI-N primer (E-A) and 4 pmol of *Taq*I-N primer (T-C). The polymerase chain reaction (PCR) program was performed as follows: 3 min at 94°C, 20 cycles of 30 s at 94°C, 1 min at 56°C and 1 min at 72°C, followed by 5 min at 72°C, and ended at 4°C. The pre-amplification products were diluted 1:20 with double-distilled water and then used as DNA templates for selective-amplification. The selective amplification was carried out with 64 primer combinations (E-ANN and T-CNN). The reaction was carried out in 12.5 μL containing 2.5 μL of diluted pre-selective amplification products, 1× *Taq* Buffer (20 mM Tris--HCl, pH 8.4, 50 mM (NH~4~)~2~SO~4~; Fermentas, USA), 3.0 mM MgCl~2~, 0.25 mM of each of the four dNTPs, 0.25 U *Taq* DNA polymerase (Fermentas, USA) and 2 pmol of *Eco*RI-NNN primer and 2 pmol of *Taq*I-NNN primer. A touchdown thermal protocol was performed, as follows: 3 min at 94°C, 2 cycles of 30 s at 94°C, 1 min at 62°C and 1 min at 72°C, reduction annealing temperature by 2°C in four steps of three cycles each. The PCR was proceeded with 20 cycles of 30 s at 94°C, 1 min at 52°C and 1 min at 72°C, followed by 5 min at 72°C, and was ended at 4°C. An aliquot of the selective amplification was added 1:10 with formamide-containing loading buffer. Denatured products (10 μL) were loaded on 6% urea-containing polyacrylamide gels and electrophoresis at a constant power of 55 W for 3 h. The gels were visualized using silver staining.

Cloning and sequencing of AFLP fragments
----------------------------------------

The AFLP fragments of interest were excised from the gel samples and eluted in 20 μL of 1× PCR buffer at 4°C overnight. The solution was boiled at 95°C for 10 min and 5 μL of DNA fragments were reamplified using the same primer for the selective amplification of the PCR conditions. The PCR products were gel purified and cloned into pGEM-T Easy vector (Promega, Madison, WI, USA) according to the manufacturer's instructions. The inserted clones were sequenced using automated sequencer CEQ8000 (Beckman Coulter, Brea, CA, USA). The sequences were analyzed for homology with NCBI (<http://www.ncbi.nlm.nih.gov/BLAST/>) and Ensembl (<http://asia.ensembl.org/Multi/blastview>) databases.

Conversion of AFLP markers into simple SNP markers and SNP genotyping
---------------------------------------------------------------------

In order to discover the polymorphisms in the restriction sites and within the AFLP fragments, the PCR fragments obtained from pigs of both extreme phenotypes were comparatively sequenced. Primer sequences were designed by covering the AFLP fragments based on the flanking sequence information acquired from the Ensembl (<http://asia.ensembl.org/index.html>) database ([Table 1](#t1-ajas-30-3-338){ref-type="table"}). The New England BioLabs cutter (NEBcutter) software (<http://nc2.neb.com/NEBcutter2/>) was used to identify the specific restriction enzymes for each SNP marker. To identify the SNP genotypes, the PCR reaction was carried out in a final volume of 20 μL containing 50 ng of genomic DNA, 1× *Taq* Buffer (20 mM Tris--HCl, pH 8.4, 50 mM (NH~4~)~2~SO~4~; Fermentas, USA), 1.5 mM MgCl~2~, 0.25 mM each of the dNTPs, 0.2 U *Taq* DNA polymerase (Fermentas, USA) and 2 pmol of each primer ([Table 1](#t1-ajas-30-3-338){ref-type="table"}). A thermal protocol was performed as follows: 3 min at 94°C; 38 cycles of 30 s at 94°C, 30 s at 58°C to 60°C and 30 s at 72°C; and the final step was done for 5 min at 72°C. The amplified fragments were digested with restriction enzymes ([Table 1](#t1-ajas-30-3-338){ref-type="table"}) and separated on 8% polyacrylamide gel electrophoresis. The gels were visualized using silver staining.

Statistical analysis
--------------------

The genotype and allele frequencies of the SNP markers were calculated. Significance of the AFLP fragment frequencies between the extreme two groups (high- and low-IMF contents) was tested using the chi-square analysis. Association analysis of the simple SNP markers with IMF content and FA composition traits was examined using a general linear model. The following statistical model was used:
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Where *y~ijklmn~* represents the observed value of the phenotype traits, μ is representative of the population mean average of the measurements, sire*~i~* represents the fixed effect of the sires (*i* = 1 to 5), dam*~j~* represents the fixed effect of the dams (*j* = 1 to 15), sex*~k~* is a fixed effect of the sexes (*k* = 1 to 2), batch*~l~* is representative of the fixed effect of the slaughter batch (*l* = 1 to 12), marker*~m~* is representative of the fixed effect of the marker genotypes (*m* = 1 to 3), and *e~ijklmn~* represents any random error. Significance was detected at the 5% level of all statistical analyzes.

RESULTS
=======

AFLP analysis
-------------

Sixty-four selective primer combinations were used to identify the AFLP markers for IMF content. A total of 1,454 markers were observed with an average of 35 amplified fragments per primer combination. The majority of the AFLP fragments ranged in size from 50 to 800 bp. From these, 145 AFLP markers were found to be polymorphic between the two extreme IMF content groups. A representative AFLP marker and the associated fragment profile are shown in [Figure 1](#f1-ajas-30-3-338){ref-type="fig"}. Twelve polymorphic fragments revealed the most striking significant differences between the two groups of high- and low-IMF contents (p\<0.05). These AFLP fragments were obtained from the selective primer combinations as shown in [Table 2](#t2-ajas-30-3-338){ref-type="table"}. From these, the AFLP fragments were cloned, sequenced and used as candidate markers for fat deposition in muscle tissue.

Identification of AFLP fragments and chromosome locations
---------------------------------------------------------

Five AFLP fragments were successfully sequenced. Homology searching and *in silico* mapping were performed using BLAST and Ensembl databases. All AFLP fragments were homology identified to the genomic DNA sequence of the pigs ([Table 3](#t3-ajas-30-3-338){ref-type="table"}). An AFLP fragment shared significant similarities with a known gene of pigs. The AFLP2 fragment showed a significant level of similarity with the porcine ankyrin repeat domain 16 (*ANKRD16*) gene (GenBank accession no. XM_013980330.1) and was located on chromosome SSC10 at 71.2 Mb. On the other hand, four AFLP fragments (AFLP1, AFLP3, AFLP7, and AFLP10) exhibited sequence identity with porcine DNA sequences (90% to 100%) and were located on chromosome SSC17 at position 61.97 Mb, SSC7 at 4.93 Mb, SSC9 at 5.49 Mb, and SSC8 at 47.33 Mb, respectively ([Table 3](#t3-ajas-30-3-338){ref-type="table"}).

To identify the causal polymorphism of these AFLP markers, the primers were designed based on the flanking sequence information that covered the AFLP fragments. The DNA fragments of the pigs that represented the IMF content extremes were amplified and comparatively sequenced. Four fragments (AFLP1, AFLP2, AFLP3, and AFLP10) were identified as SNP at the *Taq*I restriction site, selective sites or within the AFLP fragments and were named as SSC17 g.61976696G\>T, SSC10 g.712251 34G\>A, SSC7 g.4937240C\>G, and SSC8 g.47338181G\>A, respectively. The other fragment (AFLP7) was identified as insertion/deletion (Ins/Del) in the AFLP fragment and was named as SSC9 g.5496647_5496662insdel (16-bp Ins/Del).

Association of SNP markers with IMF content and FA composition
--------------------------------------------------------------

In order to elucidate the effect of the SNP markers (derived from AFLP fragments) on IMF content and FA composition, the relevant traits were investigated in pigs. Five SNP markers (SSC7 g.4937240C\>G, SSC8 g.47338181G\>A, SSC9 g.5496647_5496 662insdel, SSC10 g.71225134G\>A, and SSC17 g.61976696G\>T) were genotyped in 620 commercially crossbred pigs. Genotype and allele frequencies of these five SNP markers are shown in [Table 4](#t4-ajas-30-3-338){ref-type="table"}. The results of the association analysis of five SNP markers and the fat deposition traits in the LD muscles are shown in [Table 5](#t5-ajas-30-3-338){ref-type="table"} to [8](#t8-ajas-30-3-338){ref-type="table"}. The SSC7 g.4937240C\>G marker was found to be significantly associated with IMF content but, showed no association with any FA levels ([Table 5](#t5-ajas-30-3-338){ref-type="table"}). The SSC9 g.5496647\_ 5496662insdel marker showed a significant association with IMF content and arachidonic levels ([Table 6](#t6-ajas-30-3-338){ref-type="table"}). No association of the SSC10 g.71225134G\>A marker with IMF content was observed. However, this marker was significantly associated with palmitoleic and ω9 FA levels ([Table 7](#t7-ajas-30-3-338){ref-type="table"}). The SSC17 g.61976696G \>T marker was significantly associated with IMF content and FA levels of palmitoleic, eicosenoic, arachidonic, monounsaturated fatty acids (MUFA), and ω9 FA levels ([Table 8](#t8-ajas-30-3-338){ref-type="table"}). However, no significant association of SSC8 g.47338181G\>A with any IMF and FA composition values was observed in this study (data not shown).

DISCUSSION
==========

The AFLP approach is generally considered a powerful method of genome-wide scan technology for the QTL identification of complex traits. Several studies have successfully identified the QTLs and candidate genes for growth, meat quality and carcass traits in various livestock species \[[@b11-ajas-30-3-338],[@b12-ajas-30-3-338]\]. In the present study, the genome-wide scan for fat deposition in the muscle tissue of pigs was investigated using the AFLP approach. The selective markers were then further elucidated to determine an association with IMF content and FA levels. Four of the five candidate markers showed a significant association with IMF content and/or FA composition.

In this study, the SSC7 g.4937240C\>G marker revealed a significant association with IMF content in the crossbred pigs. This result is consistent with those of previous studies in pigs that were used to which identify the QTLs for IMF content on SSC7 at position 2.0 to 11.6 Mb \[[@b13-ajas-30-3-338]\]. The SSC7 g.4937240C\>G marker obtained from the primer combination E-AGC/T-CCA was located at position 4.93 Mb on porcine chromosome 7 close to the porcine ras responsive element binding protein 1 (*RREB1*, 4.59 Mb) gene. The *RREB1* gene encodes a zinc finger transcription factor \[[@b14-ajas-30-3-338]\]. It is involved in regulating the renin-angiotensin system. The *RREB1* variants showed an association with type 2 diabetes and end-stage kidney disease in humans \[[@b15-ajas-30-3-338]\]. It has been reported that the *RREB1* was associated with fat distribution and fasting glucose displaying potential effects related to the observed type 2 diabetes association \[[@b14-ajas-30-3-338],[@b15-ajas-30-3-338]\]. Moreover, the type 2 diabetes locus was identified in the *RREB1* region \[[@b16-ajas-30-3-338]\].

The SSC8 g.47338181G\>A marker derived from the primer combination E-AGC/T-CTG (AFLP10) was located at position 47.33 Mb on porcine chromosome 8 close to the porcine guanylate cyclase 1 soluble beta 3 (*GUCY1B3*) (46.71 Mb) gene. The *GUCY1B3* gene is a beta subunit of the soluble guanylate cyclase and belongs to the nitric oxide system. It is involved in adipose tissue biology by influencing adipogenesis, insulin-stimulated glucose uptake and lipolysis \[[@b17-ajas-30-3-338]\]. Several studies have reported on the importance of the presence of QTL for lipid accretion and IMF content on SSC8 \[[@b7-ajas-30-3-338],[@b8-ajas-30-3-338]\]. Although the AFLP10 revealed significant differences in frequency between the two groups of high- and low-IMF contents, the SNP detected in this fragment had no effect on the IMF and FA composition traits. The results indicate a lack of linkage disequilibrium between this SNP marker and the causal mutations for the studied traits in these crossbred pigs.

The SSC9 g.5496647_5496662insdel marker secured from the primer combination E-ATC/T-CGT was located at position 5.49 Mb on porcine chromosome 9 close to the porcine olfactory receptor family 51, subfamily V, member 1 (*OR51V1*, 5.46 Mb) gene. The olfactory receptor genes are a member of a large family of G-protein-coupled receptors and are encoded with single coding-exon genes. Olfactory receptors reveal a seven-transmembrane domain structure and are specifically responsible for the recognition and G protein-mediated transduction of odorant signals \[[@b18-ajas-30-3-338]\]. However, the molecular basis of the olfactory receptors for controlling fat deposition in animals is poorly understood. It has been indicated that the olfactory receptors may play a role in the sensing and regulation of dietary fat, and may be important with regard to the individual susceptibility of obesity in rats \[[@b19-ajas-30-3-338]\]. Moreover, the increasing expression levels of the olfactory receptor genes have been identified in adipose tissue during the development of obesity in mice \[[@b20-ajas-30-3-338]\]. In the present study, the SSC9 g.5496647_5496662insdel marker showed a significant association with IMF content and arachidonic levels. This result is consistent with those of previous studies which found that the QTLs for IMF content and fatty acid composition were located on the SSC9 at position 5.9 to 6.0 Mb \[[@b21-ajas-30-3-338]\] and 11.1 to 17.8 Mb \[[@b5-ajas-30-3-338]\], respectively.

The SSC10 g.71225134G\>A marker derived from the primer combination E-ACG/T-CTG showed 99% homology with porcine *ANKRD16* gene and was located at position 71.2 Mb of porcine chromosome 10. In this study, the SSC10 g.71225134G\>A marker revealed a significant association with palmitoleic and ω9 FA levels. However, this SNP was identified in the non-coding regions of the porcine *ANKRD16* gene. It has been hypothesized that the SSC10 g.71225134G\>A might be in linkage disequilibrium with other causal polymorphisms, which may be located in another region of the *ANKRD16* gene. There is a limited amount of information regarding the *ANKRD16* gene and its potential functions relating to fat deposition in pigs. However, a previous study pointed to multiple QTLs in the location of 68.0 to 76.9 Mb on SSC10, and was associated with serum lipid traits in pigs \[[@b22-ajas-30-3-338]\].

In this study, the SSC17 g.61976696G\>T marker showed a significant association with IMF content and FA composition of palmitoleic, eicosenoic, arachidonic, MUFA, and ω9 FA levels. This marker derived from the primer combination E-ACC/T-CTA was located at 61.9 Mb of porcine chromosome 17 close to the porcine cytochrome P450 family 24 subfamily A member 1 (*CYP24A1*, 61.89 Mb) and docking protein 5 (*DOK5*, 62.40 Mb) genes. The *CYP24A1* is a catabolic vitamin-D-24-hydroxylase enzyme \[[@b23-ajas-30-3-338]\] and belongs to a member of the oxygenase cytochrome P450 genes \[[@b20-ajas-30-3-338]\]. It is expressed in adipose tissue and showed a relationship with obesity in humans \[[@b24-ajas-30-3-338]\]. The trans-regulated *CYP24A1* gene revealed an association with palmitic and saturated FA contents in the muscle tissue of pigs \[[@b25-ajas-30-3-338]\]. The *DOK5* gene belongs to the downstream of the kinase family \[[@b26-ajas-30-3-338]\]. It is a substrate in the insulin signaling and is highly expressed in skeletal muscles \[[@b27-ajas-30-3-338]\]. The *DOK5* exhibited a strong association with obesity and type 2 diabetes in humans \[[@b26-ajas-30-3-338]\]. Additionally, several QTLs for IMF content and fatty acid composition traits have been identified and located within the regions at position 57.6 to 67.9 Mb on SSC17 \[[@b28-ajas-30-3-338],[@b29-ajas-30-3-338]\]. These results suggest that the SSC17 g.61976696G\>T might be in linkage disequilibrium with *CYP24A1* and *DOK5* genes.

These results highlight the importance of the selected AFLP markers. They can be used to identify the effective SNP markers for IMF content and FA composition in the muscle tissue of pigs. Additionally, the *in silico* mapping showed that the AFLP markers were located on SSC7, SSC8, SSC9, SSC10, and SSC17 and were mapped close to the strong functional candidate genes for fatness traits including, *RREB1*, *GUCY1B3*, *OR51V1*, *ANKRD16*, *CYP24A1*, and *DOK5*, respectively. These findings promote the importance of all genes as the positional candidate genes for fat deposition in the muscles of pigs. Further studies on the single nucleotide polymorphisms of these genes are required in order to identify their association with fat deposition in muscles.

In the current study, we have identified the AFLP markers for IMF content and FA composition. Four novel SNP markers (SSC7 g.4937240C\>G, SSC9 g.5496647_5496662insdel, SSC10 g.71225134G\>A, and SSC17 g.61976696G\>T) were found to be associated with IMF and/or FA content traits in commercially crossbred pigs. We demonstrated the possibility of taking advantage of the AFLP approach with regards to identification of the positional candidate genes for fat deposition in the muscle tissue of pigs.
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![A representative AFLP profile, of two extremely high and low IMF contents, was obtained with the primer combination E-AGC/T-CCA. The arrow indicates the potential AFLP fragment (AFLP3) for IMF content trait that was recovered from gels and was then analyzed further. Lane M = 100 bp DNA ladder. Lanes 1 to 20 represent DNA samples with high IMF content phenotypes and Lanes 21 to 40 represent DNA samples with low IMF content phenotypes. AFLP, amplified fragment length polymorphism; IMF, intramuscular fat.](ajas-30-3-338f1){#f1-ajas-30-3-338}

###### 

Primer sequences used for genotyping the SNP markers in pigs

  --------------------------------------------------------------------------------------------------------
  SNP marker                     Primer sequence (5′ to 3′)   Size (bp)   T~m~ (°C)   Restriction enzyme
  ------------------------------ ---------------------------- ----------- ----------- --------------------
  SSC7 g.4937240C\>G             F: TGTCTCTCCTCTTGCCCATC\     286         58          *Bsu*RI
                                 R: CAGTCAAGCCTCTTCTTGTC                              

  SSC8 g.47338181G\>A            F: CTGGCATCATCACCCTAAAC\     288         60          *Taq*I
                                 R: CCACACCAGTCTTGTGAACT                              

  SSC9 g.5496647_5496662insdel   F: GCTATGGCTTTCCCTTCTGC\     216/200     58          16-bp Ins/Del
                                 R: AGCTTCAGAGCGTCCACGAA                              

  SSC10 g.71225134G\>A           F: GCCACCAACCGAGACTACAA\     365         58          *Rsa*I
                                 R: CTACACGCGGGACAAACAAT                              

  SSC17 g.61976696G\>T           F: CTTTCTGGGTGTTCCCTCCA\     384         58          *Hin*6I
                                 R: CAGGTAACAGACTGGCAGAG                              
  --------------------------------------------------------------------------------------------------------

SNP, single nucleotide polymorphism.

###### 

Selected AFLP markers based on fragment frequency between high- and low-IMF contents in muscle tissue of pigs

  Marker   Primer combination   Fragment size (bp)   Frequency   p-value (*x*^2^)   
  -------- -------------------- -------------------- ----------- ------------------ ----------
  AFLP1    E-ACC/T-CCG          223                  0.25        0.45               0.0157
  AFLP2    E-ACG/T-CTG          71                   0.30        0.48               0.0230
  AFLP3    E-AGC/T-CCA          167                  0.15        0.43               0.0013
  AFLP4    E- AGC/T-CTG         136                  0.48        0.28               0.0106
  AFLP5    E- AGG/T-CAT         84                   0.18        0.35               0.0574
  AFLP6    E- AGG/T-CCA         188                  0.03        0.20               0.0230
  AFLP7    E-ATC/T-CGT          79                   0.05        0.28               0.0069
  AFLP8    E-ATC/T-CGA          176                  0.50        0.18               \<0.0001
  AFLP9    E-ACG/T-CTG          152                  0.15        0.35               0.0268
  AFLP10   E-AGC/T-CTG          171                  0.05        0.23               0.0336
  AFLP11   E-ATC/T-CGA          198                  0.15        0.45               0.0003
  AFLP12   E-ACG/T-CTG          145                  0.10        0.28               0.0500

AFLP, amplified fragment length polymorphism; IMF, intramuscular fat.

###### 

Characterization of AFLP markers for fat deposition in muscle tissue of pigs

  Marker   Homology      GenBank accession no.   Chromosome location (Mb)   Base pair identity (%)   Mapped close to gene
  -------- ------------- ----------------------- -------------------------- ------------------------ ----------------------
  AFLP1    porcine DNA   NC_010459.4             SSC17 (61.97)              223/223 (100)            *CYP24A1*, *DOK5*
  AFLP2    *ANKRD16*     NC_010452.3             SSC10 (71.22)              71/71 (100)              *ANKRD16*
  AFLP3    porcine DNA   NC_010449.4             SSC7 (4.93)                167/169 (99)             *RREB1*
  AFLP7    porcine DNA   NC_010451.3             SSC9 (5.49)                63/79 (90)               *OR51V1*
  AFLP10   porcine DNA   NC_010450.3             SSC8 (47.33)               171/171 (100)            *GUCY1B3*

AFLP, amplified fragment length polymorphism; *ANKRD16*, ankyrin repeat domain 16; *CYP24A1*, cytochrome P450 family 24 subfamily A member 1; *DOK5*, docking protein 5; *GUCY1B3*, guanylate cyclase 1 soluble beta 3; *OR51V1*, olfactory receptor family 51, subfamily V, member 1; *RREB1*, ras responsive element binding protein 1.

###### 

Genotype and allele frequencies of SNP markers in commercially crossbred pigs

  SNP                            N     Genotype frequency   Allele frequency                 
  ------------------------------ ----- -------------------- ------------------ ------ ------ ------
  SSC7 g.4937240C\>G             565   0.48                 0.36               0.16   0.65   0.35
  SSC8 g.47338181G\>A            513   0.64                 0.24               0.12   0.76   0.24
  SSC9 g.5496647_5496662insdel   585   0.28                 0.58               0.14   0.57   0.43
  SSC10 g.71225134G\>A           601   0.81                 0.19               0.00   0.90   0.10
  SSC17 g.61976696G\>T           570   0.52                 0.30               0.18   0.67   0.33

SNP, single nucleotide polymorphism.

Allele A represents major alleles of the SSC7 g.4937240C, SSC8 g.47338181A, SSC9 g.5496647_5496662del, SSC10 g.71225134A and SSC17 g.61976696G loci, respectively and allele B represents minor alleles of the SSC7 g.4937240G, SSC8 g.47338181G, SSC9 g.5496647_5496662ins, SSC10 g.71225134G and SSC17 g.61976696T loci, respectively.

###### 

Association of the SSC7 g.4937240C\>G marker with IMF content and fatty acid composition traits in *longissimus dorsi* muscles in commercially crossbred pigs

  Traits (%)                 Genotypes (Least squares mean±standard error)              p-value                                                                                                               
  -------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- --------
  IMF                        2.628±0.170[b](#tfn7-ajas-30-3-338){ref-type="table-fn"}   2.364±0.177[a](#tfn7-ajas-30-3-338){ref-type="table-fn"}   2.212±0.258[a](#tfn7-ajas-30-3-338){ref-type="table-fn"}   0.0454
  C14:0 (Myristic)           1.175±0.062                                                1.020±0.072                                                1.074±0.127                                                0.1241
  C16:0 (Palmitic)           13.605±1.049                                               11.539±1.221                                               12.498±2.131                                               0.2944
  C18:0 (Stearic)            12.366±0.897                                               10.827±1.044                                               10.999±1.823                                               0.3275
  C20:0 (Arachidic)          0.303±0.067                                                0.278±0.078                                                0.187±0.136                                                0.7342
  SFA                        24.451±1.429                                               23.666±1.663                                               25.759±2.903                                               0.1074
  C16:1n-9 (Palmitoleic)     3.957±0.320                                                3.534±0.373                                                4.433±0.651                                                0.4641
  C18:1n-9 (Oleic)           32.675±1.924                                               32.657±2.239                                               31.358±3.909                                               0.9581
  C20:1n-9 (Eicosenoic)      2.394±0.403                                                2.237±0.469                                                1.559±0.820                                                0.6521
  MUFA                       39.027±1.960                                               38.429±2.281                                               37.351±3.981                                               0.9093
  C18:2n-6 (Linoleic)        24.373±1.592                                               26.243±1.852                                               27.504±3.234                                               0.1572
  C18:3n-6 (Linolenic)       0.124±0.044                                                0.155±0.051                                                0.145±0.090                                                0.8318
  C20:2n-6 (Eicosadienoic)   1.682±0.251                                                1.548±0.292                                                1.925±0.509                                                0.8332
  C20:3n-6 (Homolinolenic)   0.142±0.050                                                0.274±0.058                                                0.185±0.102                                                0.1097
  C20:4n-6 (Arachidonic)     0.166±0.119                                                0.224±0.139                                                0.232±0.143                                                0.3448
  PUFA                       26.489±1.610                                               28.447±1.873                                               29.429±2.270                                               0.1637
  ω3 FA                      1.311±0.263                                                1.539±0.306                                                1.473±0.535                                                0.2251
  ω6 FA                      24.993±1.651                                               27.031±1.921                                               27.004±1.353                                               0.1657
  ω9 FA                      36.633±1.944                                               36.192±2.261                                               37.792±3.948                                               0.9673

IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).

Values in each row with different superscript letters are considered significantly different (p\<0.05).

###### 

Association of the SSC9 g.5496647_5496662insdel marker with IMF content and fatty acid composition traits in *longissimus dorsi* muscles in commercially crossbred pigs

  Traits (%)                 Genotypes (Least squares mean±standard error)              p-value                                                                                                               
  -------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- --------
  IMF                        1.716±0.269[a](#tfn9-ajas-30-3-338){ref-type="table-fn"}   2.648±0.159[a](#tfn9-ajas-30-3-338){ref-type="table-fn"}   2.526±0.304[b](#tfn9-ajas-30-3-338){ref-type="table-fn"}   0.0155
  C14:0 (Myristic)           1.150±0.243                                                1.096±0.073                                                1.025±0.103                                                0.7189
  C16:0 (Palmitic)           13.729±3.503                                               13.287±1.054                                               11.538±1.487                                               0.4236
  C18:0 (Stearic)            10.347±2.861                                               12.200±0.861                                               12.427±1.215                                               0.8258
  C20:0 (Arachidic)          0.380±0.213                                                0.348±0.064                                                0.326±0.090                                                0.5580
  SFA                        25.307±4.809                                               26.933±1.448                                               25.316±2.042                                               0.6706
  C16:1n-9 (Palmitoleic)     5.429±1.107                                                3.837±0.333                                                3.467±0.470                                                0.2907
  C18:1n-9 (Oleic)           34.674±3.855                                               34.279±1.763                                               33.626±2.486                                               0.9379
  C20:1n-9 (Eicosenoic)      1.646±1.075                                                2.424±0.384                                                1.829±0.541                                                0.3757
  MUFA                       39.224±4.899                                               40.541±1.776                                               38.924±2.505                                               0.7707
  C18:2n-6 (Linoleic)        22.838±3.009                                               22.644±1.508                                               24.971±2.127                                               0.3214
  C18:3n-6 (Linolenic)       0.158±0.138                                                0.113±0.041                                                0.68±0.058                                                 0.5761
  C20:2n-6 (Eicosadienoic)   1.267±0.804                                                1.687±0.242                                                1.513±0.341                                                0.7911
  C20:3n-6 (Homolinolenic)   0.139±0.168                                                0.179±0.050                                                0.243±0.071                                                0.4402
  C20:4n-6 (Arachidonic)     0.145±0.115[a](#tfn9-ajas-30-3-338){ref-type="table-fn"}   0.150±0.105[a](#tfn9-ajas-30-3-338){ref-type="table-fn"}   0.453±0.149[b](#tfn9-ajas-30-3-338){ref-type="table-fn"}   0.0282
  PUFA                       27.864±3.033                                               24.774±1.515                                               27.350±2.137                                               0.3266
  ω3 FA                      1.395±0.842                                                1.134±0.253                                                1.291±0.357                                                0.8691
  ω6 FA                      25.380±3.185                                               23.250±1.561                                               25.644±2.201                                               0.3371
  ω9 FA                      39.077±4.933                                               38.116±1.786                                               37.094±2.519                                               0.9032

IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).

Values in each row with different superscript letters are considered significantly different (p\<0.05).

###### 

Association of the SSC10 g.71225134G\>A marker with IMF content and fatty acid composition traits in *longissimus dorsi* muscwles in commercially crossbred pigs

  Traits (%)                 Genotypes (Least squares mean±standard error)                p-value                                                      
  -------------------------- ------------------------------------------------------------ ------------------------------------------------------------ --------
  IMF                        2.287±0.121                                                  2.397±0.282                                                  0.7155
  C14:0 (Myristic)           1.085±0.050                                                  1.208±0.171                                                  0.2614
  C16:0 (Palmitic)           13.084±0.811                                                 11.539±2.333                                                 0.5121
  C18:0 (Stearic)            11.384±0.646                                                 13.692±1.858                                                 0.2224
  C20:0 (Arachidic)          0.263±0.048                                                  0.323±0.140                                                  0.6680
  SFA                        25.819±1.127                                                 26.834±3.302                                                 0.7210
  C16:1n-9 (Palmitoleic)     3.860±0.243[a](#tfn11-ajas-30-3-338){ref-type="table-fn"}    5.323±0.699[b](#tfn11-ajas-30-3-338){ref-type="table-fn"}    0.0440
  C18:1n-9 (Oleic)           34.576±0.919                                                 36.785±2.366                                                 0.3480
  C20:1n-9 (Eicosenoic)      2.010±0.225                                                  1.581±0.648                                                  0.5126
  MUFA                       40.160±1.045                                                 44.119±2.692                                                 0.1436
  C18:2n-6 (Linoleic)        25.510±1.213                                                 22.110±3.491                                                 0.3364
  C18:3n-6 (Linolenic)       0.135±0.031                                                  0.134±0.092                                                  0.9963
  C20:2n-6 (Eicosadienoic)   1.689±0.180                                                  1.163±0.517                                                  0.3170
  C20:3n-6 (Homolinolenic)   0.181±0.038                                                  0.089±0.110                                                  0.4101
  C20:4n-6 (Arachidonic)     0.115±0.089                                                  0.034±0.257                                                  0.7549
  PUFA                       27.632±1.227                                                 23.532±3.529                                                 0.2531
  ω3 FA                      1.294±0.177                                                  0.907±0.603                                                  0.5257
  ω6 FA                      26.155±1.257                                                 23.634±3.617                                                 0.3368
  ω9 FA                      35.992±1.291[a](#tfn11-ajas-30-3-338){ref-type="table-fn"}   44.322±3.655[b](#tfn11-ajas-30-3-338){ref-type="table-fn"}   0.0284

IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).

Values in each row with different superscript letters are considered significantly different (p\<0.05).

###### 

Association of the SSC17g.61976696G\>T marker with IMF content and fatty acid composition traits in *longissimus dorsi* muscles in commercially crossbred pigs

  Traits (%)                 Genotypes (Least squares mean±standard error)                p-value                                                                                                                   
  -------------------------- ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------ --------
  IMF                        2.104±0.128[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    2.594±0.195[b](#tfn13-ajas-30-3-338){ref-type="table-fn"}    2.172±0.335[ab](#tfn13-ajas-30-3-338){ref-type="table-fn"}   0.0451
  C14:0 (Myristic)           1.123±0.068                                                  1.020±0.086                                                  1.035±0.127                                                  0.5482
  C16:0 (Palmitic)           13.107±1.013                                                 12.797±1.270                                                 11.354±1.875                                                 0.6481
  C18:0 (Stearic)            11.768±0.812                                                 12.327±1.019                                                 10.808±1.054                                                 0.6829
  C20:0 (Arachidic)          0.301± 0.062                                                 0.291±0.078                                                  0.321±0.115                                                  0.9702
  SFA                        26.301±1.373                                                 26.437±1.722                                                 23.519±2.542                                                 0.2927
  C16:1n-9 (Palmitoleic)     4.250±0.246[b](#tfn13-ajas-30-3-338){ref-type="table-fn"}    3.008±0.309[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    3.175±0.356[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    0.0153
  C18:1n-9 (Oleic)           37.334±1.145                                                 34.459±1.436                                                 38.881±2.120                                                 0.0967
  C20:1n-9 (Eicosenoic)      2.322±0.372[b](#tfn13-ajas-30-3-338){ref-type="table-fn"}    1.726±0.467[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    1.846±0.489[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    0.0491
  MUFA                       43.906±1.278[b](#tfn13-ajas-30-3-338){ref-type="table-fn"}   39.194±1.603[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}   38.904±1.565[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}   0.0255
  C18:2n-6 (Linoleic)        22.760±1.523                                                 22.848±1.910                                                 23.422±2.819                                                 0.9722
  C18:3n-6 (Linolenic)       0.145±0.039                                                  0.107±0.049                                                  0.210±0.073                                                  0.4165
  C20:2n-6 (Eicosadienoic)   1.596±0.224                                                  1.403±0.281                                                  1.242±0.415                                                  0.6608
  C20:3n-6 (Homolinolenic)   0.127±0.047                                                  0.210±0.059                                                  0.288±0.088                                                  0.1730
  C20:4n-6 (Arachidonic)     0.125±0.014[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    0.285±0.011[b](#tfn13-ajas-30-3-338){ref-type="table-fn"}    0.120±0.021[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}    0.0432
  PUFA                       24.655±1.538                                                 24.756±1.929                                                 25.370±2.847                                                 0.9684
  ω3 FA                      1.164±0.254                                                  1.100±0.319                                                  1.201±0.234                                                  0.7431
  ω6 FA                      23.297±1.575                                                 23.377±1.975                                                 24.200±2.915                                                 0.9510
  ω9 FA                      41.584±1.274[b](#tfn13-ajas-30-3-338){ref-type="table-fn"}   37.468±1.598[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}   37.638±1.859[a](#tfn13-ajas-30-3-338){ref-type="table-fn"}   0.0472

IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).

Values in each row with different superscript letters are considered significantly different (p\<0.05).
